Nutriband Inc. (NTRBW)
1.33
0.05 (3.91%)
At close: Apr 17, 2025, 12:38 PM
1.33
0.00%
After-hours: Apr 17, 2025, 04:00 PM EDT
3.91% (1D)
| Bid | 1 |
| Market Cap | 56.09M |
| Revenue (ttm) | 2.02M |
| Net Income (ttm) | -6.85M |
| EPS (ttm) | -0.505 |
| PE Ratio (ttm) | -2.64 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 1.7 |
| Volume | 136 |
| Avg. Volume (20D) | 11,601 |
| Open | 1.33 |
| Previous Close | 1.28 |
| Day's Range | 1.33 - 1.33 |
| 52-Week Range | 0.46 - 5.25 |
| Beta | 0.91 |
About NTRBW
Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain. The company has a license agreement with Rambam Med-Tech Ltd. for the development of the RAMBAM Closed System Transfer Devices. Nutriband Inc. was incorporated...
Industry Biotechnology
Sector Healthcare
IPO Date Oct 1, 2021
Employees 3
Stock Exchange NASDAQ
Ticker Symbol NTRBW
Website http://nutriband.com